BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 821607)

  • 1. Metabolism of 6-mercaptopurine in human leukemic cells.
    Higuchi T; Nakamura T; Wakisaka G
    Cancer Res; 1976 Oct; 36(10):3779-83. PubMed ID: 821607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine metabolic cycle in normal and leukemic leukocytes.
    Dietz AA; Czebotar V
    Cancer Res; 1977 Feb; 37(2):419-26. PubMed ID: 188545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical parameters of mercaptopurine activity in patients with acute lymphoblastic leukemia.
    Zimm S; Reaman G; Murphy RF; Poplack DG
    Cancer Res; 1986 Mar; 46(3):1495-8. PubMed ID: 2417705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of 6-mercaptopurine metabolism in human leukemic leukocytes and L1210 cells.
    Higuchi T; Nakamura T; Uchino H; Wakisaka G
    Antimicrob Agents Chemother; 1977 Oct; 12(4):518-22. PubMed ID: 921247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of 6-mercaptopurine metabolism in human leukemic leukocytes and L1210 cells.
    Higuchi T
    Nihon Ketsueki Gakkai Zasshi; 1975 Jun; 38(3):259-66. PubMed ID: 1243220
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphorylation of 6-mercaptopurine in human leukemic cells and phosphoribosylpyrophosphate.
    Higuchi T
    Nihon Ketsueki Gakkai Zasshi; 1975 Jun; 38(3):248-58. PubMed ID: 1243219
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha-5-phosphoribosyl-1-pyrophosphate-independent salvage of purines in cultured Chinese hamster lung fibroblasts.
    Camici M; Mura U; Cellini F; Del Corso A; Turchi G; Ipata PL
    Arch Biochem Biophys; 1988 Sep; 265(2):234-40. PubMed ID: 2458698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of phosphoribosylation of 5-fluorouracil by purines.
    Yoshida M; Hoshi A; Kuretani K
    Nucleic Acids Symp Ser; 1980; (8):s175-8. PubMed ID: 6789308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
    Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
    Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic mechanism of human hypoxanthine-guanine phosphoribosyltransferase: rapid phosphoribosyl transfer chemistry.
    Xu Y; Eads J; Sacchettini JC; Grubmeyer C
    Biochemistry; 1997 Mar; 36(12):3700-12. PubMed ID: 9132023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of amidophosphoribosyltransferase (EC2.4.2.14) and the purine phosphoribosyltransferases (EC2.4.2.7 and 2.4.2.8), and the phosphoribosylpyrophosphate content of rat central nervous system at different stages of development--their possible relationship to the neurological dysfunction in the Lesch-Nyhan syndrome.
    Allsop J; Watts RW
    J Neurol Sci; 1980 May; 46(2):221-32. PubMed ID: 6155447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of purine rescue pathways by L1210 cells exposed to methotrexate in vitro].
    Buesa JM
    Rev Esp Oncol; 1982; 29(4):641-7. PubMed ID: 6085740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Brosh S; Boer P; Kupfer B; de Vries A; Sperling O
    J Clin Invest; 1976 Aug; 58(2):289-97. PubMed ID: 956368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between rat liver epithelial and fibroblast cells in metabolism of purines.
    Berman JJ; Tong C; Williams GM
    J Cell Physiol; 1980 Jun; 103(3):393-8. PubMed ID: 6249828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purine biosynthesis in mutant mammalian cells.
    Reem GH
    Ciba Found Symp; 1977; (48):105-26. PubMed ID: 204459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo synthesis of purine nucleotides and metabolic availability of phosphoribosylpyrophosphate in leukemic leukocytes.
    Sperling O; Brosh S; Boer P; Kupfer B; Benjamin B; Weinberger A; Pinkhas J
    Biomedicine; 1979 Feb; 31(1):20-3. PubMed ID: 289423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased inhibition of HGPRT by IMP and GMP and higher levels of PRPP in an 8-azaguanine - hat resistant mutant of Chinese hamster cells.
    Simili M; Colella CM; Debatisse M; Buttin G
    Cell Biol Int Rep; 1983 Feb; 7(2):121-8. PubMed ID: 6188543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered 5-phosphoribosyl 1-pyrophosphate amidotransferase activity in 6-thioguanine-resistant HL-60 human acute promyelocytic leukemia cells.
    Ishiguro K; Sartorelli AC
    Cancer Res; 1984 Sep; 44(9):3679-85. PubMed ID: 6589043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of 6-mercaptopurine in human leukemic cells.
    Higuchi T
    Nihon Ketsueki Gakkai Zasshi; 1974 Jun; 37(3):282-8. PubMed ID: 4479918
    [No Abstract]   [Full Text] [Related]  

  • 20. Retention of 6-mercaptopurine derivatives by intact cells as an index of drug response in human and murine leukemias.
    Kessel D; Hall TC
    Cancer Res; 1969 Nov; 29(11):2116-9. PubMed ID: 5390826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.